Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: Data from a large community-based cohort study

Journal of Women's Health

Volumn 24, Issue 4, 2015, Pages 299-307

  Joham, Anju E ^a,b   Teede, Helena J ^a,b   Ranasinha, Sanjeeva ^a   Zoungas, Sophia ^a,b   Boyle, Jacqueline ^a  

^a MONASH UNIVERSITY   (Australia)

^b SOUTHERN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONAL THERAPY; HUMAN; INFERTILITY THERAPY; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREVALENCE; PRIORITY JOURNAL; SELF CONCEPT; ADOLESCENT; ADVERSE EFFECTS; AUSTRALIA; COMPLICATION; CROSS-SECTIONAL STUDY; INFERTILITY, FEMALE; MULTIVARIATE ANALYSIS; OBESITY; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY RATE; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; AUSTRALIA; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; OBESITY; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY RATE; PREVALENCE; YOUNG ADULT;

EID: 84928004636     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2014.5000     Document Type: Article

References (39)

1. March WA, Moore VM, Willson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010;25:544-51.
2. Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745-2749.
3. Asuncion M, Calvo RM, San Millan JL, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434-3515.
4. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999;84:4006-4011.
5. Boyle JA, Cunningham J, O'Dea K, Dunbar T, Norman RJ. Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia. Med J Aust 2012;196:62-66.
6. Teede H, Deeks A, Moran L. Polycystic ovary syndrome: A complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Medicine 2010;8:41.
7. Diamanti-Kandarakis E, Papavassiliou AG. Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med 2006;12:324-332.
8. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
9. Azziz R, Carmina E, Dewailly D, et al. Positions statement: Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline. J Clin Endocrinol Metab 2006;91: 4237-4245.
10. Teede HJ, Hutchison SK, Zoungas S. The management of insulin resistance in polycystic ovary syndrome. Trends Endocrinol Metab 2007;18:273-279.
11. Meyer C, McGrath B, Cameron J, Teede H. Vascular dysfunction and metabolic parameters in polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:4630-4635.
12. Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obes 2002;26:883-896.
13. Teede HJ, Joham AE, Paul E, et al. Longitudinal weight gain in women identified with polycystic ovary syndrome: Results of an observational study in young women. Obesity 2013;21:1526-1532.
14. Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod Update 2012;18:618-37.
15. Ramanand SJ, Ghongane BB, Ramanand JB, et al. Clinical characteristics of polycystic ovary syndrome in Indian women. Indian J Endocr Metab 2013;17: 138-145.
16. Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG 2006;113:1148-1159.
17. Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod 2012;27:3067-3073.
18. Balen AH, Conway GS, Kaltsas G, et al. Polycystic ovary syndrome: The spectrum of the disorder in 1741 patients. Hum Reprod 1995;10:2107-2111.
19. Kiddy DS, Sharp PS, White DM, et al. Differences in clinical and endocrine features between obese and nonobese subjects with polycystic ovary syndrome: An analysis of 263 consecutive cases. Clin Endocrinol (Oxf) 1990;32:213-220.
20. Zaadstra BM, Seidell JC, Van Noord PA, et al. Fat and female fecundity: Prospective study of effect of body fat distribution on conception rates. BMJ 1993;306:484-487.
21. van der Steeg JW, Steures P, Eijkemans MJ, et al. Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum Reprod 2008;23:324-328.
22. Kumbak B, Oral E, Bukulmez O. Female obesity and assisted reproductive technologies. Semin Reprod Med 2012;30:507-516.
23. Pasquali R, Patton L, Gambineri A. Obesity and infertility. Curr Opin Endocrinol Diabetes Obes 2007;14:482-487.
24. Wild S, Pierpoint T, Jacobs H, McKeigue P. Long-term consequences of polycystic ovary syndrome: Results of a 31 year follow-up study. Hum Fertil (Camb) 2000;3:101-105.
25. Roos N, Kieler H, Sahlin L, et al. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study. BMJ 2011;343: d6309.
26. Lee C. Women's Health Australia: Progress on the Australian Longitudinal Study on Women's Health 1995-2000. Brisbane: Australian Academic Press Pty Ltd., 2001.
27. Lee C, Dobson AJ, Brown WJ, et al. Cohort profile: The Australian Longitudinal Study on Women's Health. Int J Epidemiol 2005;34:987-991.
28. Powers J, Loxton D. The impact of attrition in an 11-year prospective longitudinal study of younger women. Ann Epidemiol 2010;20:318-321.
29. Brown WJ, Bryson L, Byles JE, et al. Women's Health Australia: Recruitment for a national longitudinal cohort study. Women Health 1998;28:23-40.
30. World Health Organization (WHO). Obesity: Preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series 894. Geneva: World Health Organization, 1998.
31. Hudecova M, Holte J, Olovsson M, Sundstrom Poromaa I. Long-term follow-up of patients with polycystic ovary syndrome: Reproductive outcome and ovarian reserve. Hum Reprod 2009;24:1176-1183.
32. Hull MG. Epidemiology of infertility and polycystic ovarian disease: Endocrinological and demographic studies. Gynecol Endocrinol 1987;1:235-245.
33. Azziz R, Marin C, Hoq L, Badamgarav E, Song P. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab 2005;90:4650-4658.
34. Wang Y, Macaldowie A, Hayward I, Chambers G, Sullivan E. Assisted reproductive technology in Australia and New Zealand 2009. Canberra: Australian Institute of Health and Welfare (AIHW), 2011.
35. Bablok L, Dziadecki W, Szymusik I, et al. Patterns of infertility in Poland - multicenter study. Neuro Endocrinol Lett 2011;32:799-804.
36. Stepto NK, Cassar S, Joham AE, et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod 2013; 28:777-784.
37. Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ. Treatment of obesity in polycystic ovary syndrome: A position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril 2009;92:1966-1982.
38. Teede H, Misso M, Deeks A, et al. Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline. Med J Aust 2011;195:S65-S112.
39. The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). College statement: Ovarian stimulation in infertility.. (C-Gyn 02). Melbourne: RANZCOG, 2008.